CLINICAL_TRIALS
trial_result
· 2024-03-27
Clinical Trial Update: Use of Botulinum Toxin in the Treatment of Androgenic Alopecia [Phase 2]
Summary
Phase 2 trial update on botulinum toxin for androgenetic alopecia (androgenetic alopecia) indicating ongoing status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zel Skin and Laser Specialists | Conditions: Androgenetic Alopecia | Phase 2 | Status: ACTIVE_NOT_RECRUITING